These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 9923056
21. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. Baroody FM, Shenaq D, DeTineo M, Wang J, Naclerio RM. J Allergy Clin Immunol; 2009 Jun; 123(6):1342-8. PubMed ID: 19428097 [Abstract] [Full Text] [Related]
25. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis. Lieberman P, Kaliner MA, Wheeler WJ. Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111 [Abstract] [Full Text] [Related]
26. Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis. Svensson C, Andersson M, Greiff L, Blychert LO, Persson CG. Allergy; 1998 Apr; 53(4):367-74. PubMed ID: 9574878 [Abstract] [Full Text] [Related]
27. [Clinical assessment of azelastine nasal spray in seasonal allergic rhinitis]. Arcimowicz M, Samoliński B, Zawisza E. Pol Merkur Lekarski; 1998 Dec; 5(30):363-7. PubMed ID: 10101526 [Abstract] [Full Text] [Related]
28. Interactive effect of histamine and prostaglandin D2 on nasal allergic symptoms in rats. Rahman A, Inoue T, Ago J, Ishikawa T, Kamei C. Eur J Pharmacol; 2007 Jan 12; 554(2-3):229-34. PubMed ID: 17112500 [Abstract] [Full Text] [Related]
29. Inhibitory effect of levocabastine on allergen-induced increase of nasal reactivity to histamine and cell influx. Pazdrak K, Górski P, Ruta U. Allergy; 1993 Nov 12; 48(8):598-601. PubMed ID: 7906926 [Abstract] [Full Text] [Related]
30. Histamine releasability after adenosine challenge in subjects with allergic and non-allergic rhinitis: possible implications for mast cell priming. Polosa R, Pagano C, Low JL, Church MK, Crimi N. Ann Ital Med Int; 1999 Nov 12; 14(2):86-93. PubMed ID: 10399370 [Abstract] [Full Text] [Related]
33. Onset of action of a topical antihistamine as assessed by histamine challenge-induced plasma exudation responses. Korsgren M, Andersson M, Larsson L, Aldén-Raboisson M, Greiff L. Ann Allergy Asthma Immunol; 2006 Feb 12; 96(2):345-8. PubMed ID: 16498858 [Abstract] [Full Text] [Related]
34. Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions. Corren J, Rachelefsky G, Spector S, Schanker H, Siegel S, Holton D, Karcher K, Travers S. J Allergy Clin Immunol; 1999 Apr 12; 103(4):574-80. PubMed ID: 10200003 [Abstract] [Full Text] [Related]
35. Effect of a new selective H1 receptor antagonist (levocabastine) in a nasal and conjunctival provocation test. Pécoud A, Zuber P, Kolly M. Int Arch Allergy Appl Immunol; 1987 Apr 12; 82(3-4):541-3. PubMed ID: 2883132 [Abstract] [Full Text] [Related]
39. The effect of levocabastine and furosemide pretreatment on hyperreactive response after nasal provocation with hypotonic aerosol in subjects with allergic rhinitis. Anzic SA, Dzepina D, Kalogjera L. Eur Arch Otorhinolaryngol; 2007 Nov 12; 264(11):1309-14. PubMed ID: 17618447 [Abstract] [Full Text] [Related]